Aurora Cannabis is urging shareholders to reject Curaleaf’s hostile bid while highlighting approximately $149 million in cash. Aurora says the proposal would give Curaleaf control of cash belonging to shareholders and replace ownership of a debt-free Business with Curaleaf shares, exposing investors to the bidder’s Debt and other stated risks.

Key Highlights

  • Curaleaf carries more than $1 billion in debt, Aurora says.
  • Aurora’s special committee and board received a written financial-adviser opinion dated September 1.
  • Aurora says Curaleaf would gain control of remaining Shareholder funds upon closing.

Aurora Cannabis Inc. (NASDAQ: ACB) is urging shareholders to reject Curaleaf’s hostile bid, saying the offer undervalues the business and puts future upside at risk. Aurora says it had approximately $149 million in cash as of June 30, 2026, and that shareholders would receive only part of that value if the transaction closes.

Aurora Challenges Curaleaf’s Offer

Aurora says the proposal values its business at a significant discount to other cannabis companies and provides no meaningful change-of-control premium. The company also argues that Curaleaf’s premium calculation presents a more favorable picture than the value shareholders would actually receive.

Cash Ownership and Shareholder Exposure

Aurora says it is debt-free, while Curaleaf has more than $1 billion in debt. Under the hostile bid, Curaleaf would gain control of Aurora’s remaining shareholder cash after closing, while Aurora investors would receive Curaleaf shares.

Peers Moving on This News